These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14694212)

  • 1. Central adiposity determines prevalence differences of the metabolic syndrome.
    Lorenzo C; Serrano-Ríos M; Martínez-Larrad MT; Gabriel R; Williams K; Gómez-Gerique JA; Stern MP; Haffner SM
    Obes Res; 2003 Dec; 11(12):1480-7. PubMed ID: 14694212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects.
    Lorenzo C; Serrano-Ríos M; Martínez-Larrad MT; González-Sánchez JL; Seclén S; Villena A; Gonzalez-Villalpando C; Williams K; Haffner SM
    Diabetes Care; 2006 Mar; 29(3):685-91. PubMed ID: 16505527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hypertension in Hispanic and non-Hispanic white populations.
    Lorenzo C; Serrano-Rios M; Martinez-Larrad MT; Gabriel R; Williams K; Gonzalez-Villalpando C; Stern MP; Hazuda HP; Haffner S
    Hypertension; 2002 Feb; 39(2):203-8. PubMed ID: 11847184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate-to-severe diabetic retinopathy is more prevalent in Mexico City than in San Antonio, Texas.
    González Villalpando ME; González Villalpando C; Arredondo Pérez B; Martínez Díaz SV; Mitchell B; Rivera Martínez D; Klein R; Haffner SM; Stern MP
    Diabetes Care; 1997 May; 20(5):773-7. PubMed ID: 9135941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
    Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
    Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2006 Mar; 29(3):625-30. PubMed ID: 16505517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study.
    Lorenzo C; Serrano-Rios M; Martinez-Larrad MT; Gabriel R; Williams K; Gonzalez-Villalpando C; Stern MP; Hazuda HP; Haffner SM
    Diabetes Care; 2001 Dec; 24(12):2059-64. PubMed ID: 11723083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupation is more important than rural or urban residence in explaining the prevalence of metabolic and cardiovascular disease risk in Guatemalan adults.
    Gregory CO; Dai J; Ramirez-Zea M; Stein AD
    J Nutr; 2007 May; 137(5):1314-9. PubMed ID: 17449598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.
    Meigs JB; Wilson PW; Nathan DM; D'Agostino RB; Williams K; Haffner SM
    Diabetes; 2003 Aug; 52(8):2160-7. PubMed ID: 12882936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
    Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM
    Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study.
    Mitchell BD; Stern MP; Haffner SM; Hazuda HP; Patterson JK
    Am J Epidemiol; 1990 Mar; 131(3):423-33. PubMed ID: 2301352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction and cardiovascular risk factors in Mexico City and San Antonio, Texas.
    Mitchell BD; González Villalpando C; Arredondo Pérez B; García MS; Valdez R; Stern MP
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):721-5. PubMed ID: 7773724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between surrogate measures of insulin resistance and waist circumference, cardiovascular risk and the metabolic syndrome across Hispanic and non-Hispanic white populations.
    Martínez-Larrad MT; Lorenzo C; González-Villalpando C; Gabriel R; Haffner SM; Serrano-Ríos M
    Diabet Med; 2012 Nov; 29(11):1390-4. PubMed ID: 22681498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations.
    Agyemang C; van Valkengoed IG; van den Born BJ; Bhopal R; Stronks K
    Diabet Med; 2012 Sep; 29(9):1159-64. PubMed ID: 22356260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico.
    Burke JP; Williams K; Haffner SM; Villalpando CG; Stern MP
    Diabetes Care; 2001 Sep; 24(9):1573-8. PubMed ID: 11522701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).
    Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V
    Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body adiposity index and cardiovascular health risk factors in Caucasians: a comparison with the body mass index and others.
    Bennasar-Veny M; Lopez-Gonzalez AA; Tauler P; Cespedes ML; Vicente-Herrero T; Yañez A; Tomas-Salva M; Aguilo A
    PLoS One; 2013; 8(5):e63999. PubMed ID: 23734182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.
    Burke JP; Williams K; Gaskill SP; Hazuda HP; Haffner SM; Stern MP
    Arch Intern Med; 1999 Jul; 159(13):1450-6. PubMed ID: 10399896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity.
    Lorenzo C; Williams K; Gonzalez-Villalpando C; Haffner SM
    Diabetes Care; 2005 Oct; 28(10):2480-5. PubMed ID: 16186283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis of the insulin-resistance syndrome (syndrome X).
    Haffner SM; Valdez RA; Hazuda HP; Mitchell BD; Morales PA; Stern MP
    Diabetes; 1992 Jun; 41(6):715-22. PubMed ID: 1587398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.